Eli Lilly’s trial weight-loss drug reduces heart failure risk by 38%
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.
Intensive diet and lifestyle changes may forestall a cognitive decline in Alzheimer’s disease and make progress for patients during early stages, a study.
HQ Team February 16, 2024: Diet fads are common. Every few months the world gets excited about one kind of diet or the.
By Dr K. Leelamoni November 7, 2023: My cousin’s son, 46, went to a hospital in the southern Indian state of Kerala as.
A new study says that neural pathways that control hunger pangs become overactive during dieting and inhibiting their progress may be the key.
Consumption of fast food may lead to nonalcoholic fatty liver disease, a life-threatening condition, according to researchers from the Keck School of Medicine.
A new study reveals cellular changes that take place in response to exercise and high-fat diets